PAD Growth Account Manager – Artix & LimFlow

Stryker; United States; On-site; USD 113,000 - 138,000; Full time

Benefits offered by this job

Health benefits

401(k) plan

Employee Stock Purchase Plan

Wellbeing program

Job summary

The Arterial Account Manager at Stryker drives growth across Peripheral Arterial Disease (PAD), focusing on the Artix and LimFlow portfolios. The role requires autonomous judgement and close collaboration with interventionalists, vascular surgeons, and cross-functional teams to develop and scale PAD programs within assigned accounts.

Key responsibilities include identifying growth opportunities, building stakeholder alignment, driving adoption through clinical excellence and education, and

Qualifications

• Bachelor's degree or 6 years demonstrated sales experience.
• Minimum 4 years preferred peripheral vascular arterial sales experience.
• Maintain all Certifications and Vendor Credentials.
• Demonstrate consistent quota attainment.
• Able to travel extensively (70-80%).

Responsibilities

• Proactively identify growth opportunities in PAD and CLTI markets.
• Build and influence multi-disciplinary stakeholder alignment.
• Drive adoption through clinical excellence and program-building initiatives.
• Expand access and grow long-term franchise value for Artix and LimFlow.
• Collaborate with regional teams to coordinate new hire/account manager assignments.
• Represent the company at trade shows and prepare required reports.
• Develop clinical/technical content with Medical Education for national calls.

Education

Bachelor's degree preferred

Job description

The Arterial Account Manager at Stryker drives growth across Peripheral Arterial Disease (PAD), focusing on the Artix and LimFlow portfolios. The role requires autonomous judgement and close collaboration with interventionalists, vascular surgeons, and cross-functional teams to develop and scale PAD programs within assigned accounts.

Key responsibilities include identifying growth opportunities, building stakeholder alignment, driving adoption through clinical excellence and education, and